Cargando…

Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis

Hepatocellular Carcinoma (HCC) is one of the leading causes of cancer-associated mortality worldwide. However, the role of epigenetic changes such as aberrant DNA methylation in hepatocarcinogenesis remains largely unclear. In this study, we examined the methylation profiles of 59 HCC patients. Usin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mah, Way-Champ, Thurnherr, Thomas, Chow, Pierce K. H., Chung, Alexander Y. F., Ooi, London L. P. J., Toh, Han Chong, Teh, Bin Tean, Saunthararajah, Yogen, Lee, Caroline G. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122406/ https://www.ncbi.nlm.nih.gov/pubmed/25093504 http://dx.doi.org/10.1371/journal.pone.0104158

Ejemplares similares

Correction: Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis
por: Mah, Way-Champ, et al.
Publicado: (2016)

Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways
por: Thurnherr, Thomas, et al.
Publicado: (2016)

DNA methylation: potential biomarker in Hepatocellular Carcinoma
por: Mah, Way-Champ, et al.
Publicado: (2014)

Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma
por: Jin, Yu, et al.
Publicado: (2019)

Targeting sickle cell disease root-cause pathophysiology with small molecules
por: Saunthararajah, Yogen
Publicado: (2019)

Mysteries of partial dihydroorotate dehydrogenase inhibition and leukemia terminal differentiation
por: Saunthararajah, Yogen
Publicado: (2020)

Clinicopathological-Associated Regulatory Network of Deregulated circRNAs in Hepatocellular Carcinoma
por: Han, Jian, et al.
Publicado: (2021)

Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify a subgroup with poor prognosis
por: Chedere, Adithya, et al.
Publicado: (2022)

Severe pyoderma gangrenosum caused by myelodysplastic syndrome successfully treated with decitabine administered by a noncytotoxic regimen
por: Saleh, Mostafa F. M., et al.
Publicado: (2017)

5-aza-2′,2′-Difluroro Deoxycytidine (NUC013): A Novel Nucleoside DNA Methyl Transferase Inhibitor and Ribonucleotide Reductase Inhibitor for the Treatment of Cancer
por: Daifuku, Richard, et al.
Publicado: (2017)

Silibinin down-regulates FAT10 and modulate TNF-α/IFN-γ-induced chromosomal instability and apoptosis sensitivity
por: Gao, Yun, et al.
Publicado: (2015)

Network of clinically-relevant lncRNAs-mRNAs associated with prognosis of hepatocellular carcinoma patients
por: Lim, Lee Jin, et al.
Publicado: (2020)

Highly deregulated lncRNA LOC is associated with overall worse prognosis in Hepatocellular Carcinoma patients
por: Lim, Lee Jin, et al.
Publicado: (2021)

Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells
por: Enane, Francis O., et al.
Publicado: (2018)

Mutational interactions define novel cancer subgroups
por: Kuipers, Jack, et al.
Publicado: (2018)

High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects
por: Ebrahem, Quteba, et al.
Publicado: (2012)

Identification of Anoikis-Related Subgroups and Prognosis Model in Liver Hepatocellular Carcinoma
por: Chen, Yutong, et al.
Publicado: (2023)

Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma
por: Garnelo, Marta, et al.
Publicado: (2017)

MicroRNA-224 Targets SMAD Family Member 4 to Promote Cell Proliferation and Negatively Influence Patient Survival
por: Wang, Yu, et al.
Publicado: (2013)

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

Infiltration of a Unique CD8(+)CD274(+) Cell Subgroup in Hepatocellular Carcinoma is Associated with Poor Clinical Outcomes
por: Zhang, Yong, et al.
Publicado: (2023)

[(18)F] Clofarabine for PET Imaging of Hepatocellular Carcinoma
por: Sergeeva, Olga, et al.
Publicado: (2019)

Distinct symptom experiences in subgroups of patients with COPD
por: Christensen, Vivi L, et al.
Publicado: (2016)

Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups
por: Gomez-Bougie, Patricia, et al.
Publicado: (2014)

Expression of HIF-1α in medullary thyroid cancer identifies a subgroup with poor prognosis
por: Lodewijk, Lutske, et al.
Publicado: (2017)

ATRT-12. LIN28A expression correlates with poor prognosis and the MYC subgroup in AT/RTs
por: Dottermusch, Matthias, et al.
Publicado: (2022)

Decitabine Suspends Human CD34(+) Cell Differentiation and Proliferation during Lentiviral Transduction
por: Uchida, Naoya, et al.
Publicado: (2014)

Clinical Trials Assessing Hypomethylating Agents Combined with Other Therapies: Causes for Failure and Potential Solutions
por: Zavras, Phaedon D., et al.
Publicado: (2021)

DNA Methyltransferase 1 Targeting Using Guadecitabine Inhibits Prostate Cancer Growth by an Apoptosis-Independent Pathway
por: Karan, Dev, et al.
Publicado: (2023)

Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma
por: Triozzi, Pierre L., et al.
Publicado: (2016)

A non‐cytotoxic regimen of decitabine to treat refractory T‐cell large granular lymphocytic leukemia
por: Zawit, Misam, et al.
Publicado: (2021)

Rare FGFR fusion genes in cervical cancer and transcriptome‐based subgrouping of patients with a poor prognosis
por: Hiranuma, Kengo, et al.
Publicado: (2023)

Novel mutations target distinct subgroups of medulloblastoma
por: Robinson, Giles, et al.
Publicado: (2012)

Identification of PANoptosis-relevant subgroups to evaluate the prognosis and immune landscape of patients with liver hepatocellular carcinoma
por: Zhang, Zhengwei, et al.
Publicado: (2023)

Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies
por: Leclair, Valérie, et al.
Publicado: (2023)

Tracking Decitabine Incorporation into Malignant Myeloid Cell DNA in vitro and in vivo by LC-MS/MS with Enzymatic Digestion
por: Chilakala, Sujatha, et al.
Publicado: (2019)

Changing paradigms in oncology: Toward noncytotoxic treatments for advanced gliomas
por: von Knebel Doeberitz, Nikolaus, et al.
Publicado: (2022)

The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma
por: Ang, Soo Fan, et al.
Publicado: (2015)

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014)

Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
por: Luo, Rongzhen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_eq7tftcmld81p1q1sbri7jopk4